Quan M, Chen J, Chen Z, Hai Y, et al. Cetuximab retreatment plus camrelizumab and liposomal irinotecan in patients with RAS wild-type metastatic colorectal cancer: Cohort B of the phase II CRACK study. Int J Cancer 2023 May 10. doi: 10.1002/ijc.34531.
PMID: 37163613